AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/
Authors: CURE H KRAKOWSKI I ADENIS A TUBIANA N KERBRAT P ROCHE H CHEVALLIER B LENTZ MA FUMOLEAU P CHOLLET P
Citation: H. Cure et al., RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/, European journal of cancer, 34(3), 1998, pp. 422-423
PRELIMINARY ANTIEMETIC EFFICACY AND PHARMACOKINETICS OF THE NK1 RECEPTOR ANTAGONIST GR205171 IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY
Authors: FUMOLEAU P GRAHAM E GIOVANNINI M MARTY M MCQUADE B PALMER J
Citation: P. Fumoleau et al., PRELIMINARY ANTIEMETIC EFFICACY AND PHARMACOKINETICS OF THE NK1 RECEPTOR ANTAGONIST GR205171 IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 687-687
A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS
Authors: FUMOLEAU P TUBIANAHULIN M SOULIE P DELECROIX V SISTAC F MEFTI F SOULAS F APPIA F LEBECQ A VERGNIOL JC VERNILLET L RIVA A
Citation: P. Fumoleau et al., A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 387-387
AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/
Authors: DEGARDIN M OLIVEIRA J GEOFFROIS L ROLLAND F ARMAND JP BASTIT P CHAUVERGNE J FARGEOT P VANGLABBEKE M LENTZ MA TRESCA P BOUDILLET J FUMOLEAU P CAPPELAERE P
Citation: M. Degardin et al., AN EORTC-ECSG PHASE-II STUDY OF VINORELBINE IN PATIENTS WITH RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, Annals of oncology, 9(10), 1998, pp. 1103-1107
POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/
Authors: BRUNO R HILLE D RIVA A VIVIER N HUINNINK WWTB VANOOSTEROM AT KAYE SB VERWEIJ J FOSSELLA FV VALERO V RIGAS JR SEIDMAN AD CHEVALLIER B FUMOLEAU P BURRIS HA RAVCLIN PM SHEINER LB
Citation: R. Bruno et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/, Journal of clinical oncology, 16(1), 1998, pp. 187-196
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
ONDANSETRON SUPPOSITORY - AN EFFECTIVE TREATMENT FOR THE PREVENTION OF EMETIC DISORDERS INDUCED BY CISPLATIN-BASED CHEMOTHERAPY
Authors: FUMOLEAU P GIOVANNINI M ROLLAND F VOTAN B PAILLARSE JM",AUBIER,AUDHUY,BAILLET,BALMES,BERGERAT,BERNARD,BOBIN,BRUNET,CAILLAUD,CARLES,CATIMEL,CLAVERE,CLAVIER,CHOMY,COLIN,CONINX,DAVID,DUTIN,FRUGE,GANEM,KHAYAT,LAFITTE,LAPLAIGE,MARTIN,MIECH,MORVAN,MOUSSEAU,MUIR,NOUVET,PENY,PERPOINT,PESSEY,PUJADELAURAINE,ROMIEU,SEVIN,STERN,TAULELLE,TUBIANA,TUBIANA,VANNETZEL,VERRELLE,ZYLBERBERG
Citation: P. Fumoleau et al., ONDANSETRON SUPPOSITORY - AN EFFECTIVE TREATMENT FOR THE PREVENTION OF EMETIC DISORDERS INDUCED BY CISPLATIN-BASED CHEMOTHERAPY, Oral Oncology, 33(5), 1997, pp. 354-358
EFFICACY AND SAFETY OF DOCETAXEL IN CLINICAL-TRIALS
Authors: FUMOLEAU P
Citation: P. Fumoleau, EFFICACY AND SAFETY OF DOCETAXEL IN CLINICAL-TRIALS, American journal of health-system pharmacy, 54, 1997, pp. 19-24
ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS
Authors: FUMOLEAU P CHAUVIN F NAMER M BUGAT R TUBIANAHULIN M GUASTALLA JP DELOZIER T KERBRAT P DEVAUX Y FILLEUL A
Citation: P. Fumoleau et al., ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS, European journal of cancer, 33, 1997, pp. 351-351
ACTIVITY OF GEMCITABINE IN METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH ANTHRACYCLINE-CONTAINING REGIMENS
Authors: SPIELMANN M KALLA S LLOMBARTCUSSAC A ESPIE M NAMER M FERRERO JM CUVIER C FUMOLEAU P PONZIO A KAYITALIRE L POUILLART P
Citation: M. Spielmann et al., ACTIVITY OF GEMCITABINE IN METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH ANTHRACYCLINE-CONTAINING REGIMENS, European journal of cancer, 33, 1997, pp. 663-663
ANTHRACYCLINE AS 2ND LINE CHEMOTHERAPY (CT) FOR METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH TAXOTERE (TXT)
Authors: DELECROIX V FUMOLEAU P PERROCHEAU G AZLI N FETY R PRIOU F MAUGARD C RIVA A LEMEVEL B
Citation: V. Delecroix et al., ANTHRACYCLINE AS 2ND LINE CHEMOTHERAPY (CT) FOR METASTATIC BREAST-CANCER (MBC) PATIENTS PREVIOUSLY TREATED WITH TAXOTERE (TXT), European journal of cancer, 33, 1997, pp. 666-666
ABSOLUTE BIOAVAILABILITY AND PHARMACOKINETICS (PK) OF ORAL VINORELBINE (VRL) IN PATIENTS (PTS) WITH SOLID TUMORS
Authors: PUOZZO C FUMOLEAU P ADENIS A ROUSSEAU F MERROUCHE Y ROBINET G SENAC I MARTY M
Citation: C. Puozzo et al., ABSOLUTE BIOAVAILABILITY AND PHARMACOKINETICS (PK) OF ORAL VINORELBINE (VRL) IN PATIENTS (PTS) WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1118-1118
DOCETAXEL IN COMBINATION WITH DOXORUBICIN OR VINORELBINE
Authors: DIERAS V FUMOLEAU P KALLA S MISSET JL AZLI N POUILLART P
Citation: V. Dieras et al., DOCETAXEL IN COMBINATION WITH DOXORUBICIN OR VINORELBINE, European journal of cancer, 33, 1997, pp. 20-22
RESULTS OF A PHASE-II TRIAL WITH CYSTEMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP
Authors: UROSEVIC V CHOLLET P ADENIS A CHAUVERGNE J FARGEOT P ROCHE H KERBRAT P LENTZ MA FUMOLEAU P CHEVALLIER B
Citation: V. Urosevic et al., RESULTS OF A PHASE-II TRIAL WITH CYSTEMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer, 32A(1), 1996, pp. 181-182
TREATMENT OF PATIENTS WITH LIVER METASTASES
Authors: FUMOLEAU P
Citation: P. Fumoleau, TREATMENT OF PATIENTS WITH LIVER METASTASES, Anti-cancer drugs, 7, 1996, pp. 21-23
TAXOIDS IN COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
Authors: DIERAS V FUMOLEAU P BOURGEOIS H MISSET JL AZLI N POUILLART P
Citation: V. Dieras et al., TAXOIDS IN COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Anti-cancer drugs, 7, 1996, pp. 47-52
CHEVALLIER,BERNARD (1954-1996) - OBITUARY
Authors: VERWEIJ J FUMOLEAU P HANAUSKE A
Citation: J. Verweij et al., CHEVALLIER,BERNARD (1954-1996) - OBITUARY, Annals of oncology, 7(6), 1996, pp. 545-545
A MULTICENTER PHASE-II STUDY OF THE EFFICACY AND SAFETY OF DOCETAXEL AS FIRST-LINE TREATMENT OF ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC
Authors: FUMOLEAU P CHEVALLIER B KERBRAT P KRAKOWSKI Y MISSET JL MAUGARDLOUBOUTIN C DIERAS V AZLI N BOUGON N RIVA A ROCHE H
Citation: P. Fumoleau et al., A MULTICENTER PHASE-II STUDY OF THE EFFICACY AND SAFETY OF DOCETAXEL AS FIRST-LINE TREATMENT OF ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC, Annals of oncology, 7(2), 1996, pp. 165-171
ADJUVANT TREATMENT OF NODE-POSITIVE BREAST-CANCER WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, FLUOROURACIL AND VINCRISTINE VERSUS CYCLOPHOSPHAMIDE,METHOTREXATE, AND FLUOROURACIL - FINAL REPORT AFTER A 16-YEAR MEDIAN FOLLOW-UP DURATION
Authors: MISSET JL DIPALMA M DELGADO M PLAGNE R CHOLLET P FUMOLEAU P LEMEVEL B BELPOMME D GUERRIN J FARGEOT P METZ R ITHZAKI M HILL C MATHE G
Citation: Jl. Misset et al., ADJUVANT TREATMENT OF NODE-POSITIVE BREAST-CANCER WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, FLUOROURACIL AND VINCRISTINE VERSUS CYCLOPHOSPHAMIDE,METHOTREXATE, AND FLUOROURACIL - FINAL REPORT AFTER A 16-YEAR MEDIAN FOLLOW-UP DURATION, Journal of clinical oncology, 14(4), 1996, pp. 1136-1145
INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY
Authors: PUJADELAURAINE E GUASTALLA JP COLOMBO N DEVILLIER P FRANCOIS E FUMOLEAU P MONNIER A NOOY M MIGNOT L BUGAT R MARQUES C MOUSSEAU M NETTER G MALOISEL F LARBAOUI S BRANDELY M
Citation: E. Pujadelauraine et al., INTRAPERITONEAL RECOMBINANT INTERFERON-GAMMA IN OVARIAN-CANCER PATIENTS WITH RESIDUAL DISEASE AT 2ND-LOOK LAPAROTOMY, Journal of clinical oncology, 14(2), 1996, pp. 343-350
CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY
Authors: LHOMME C KERBRAT P LEJEUNE C GUASTALLA JP FUMOLEAU P GOUPIL A HERON JF CASSIN MA PRUVOT I SOARES JA CHAZARD M
Citation: C. Lhomme et al., CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY, Seminars in oncology, 23(5), 1996, pp. 48-54
INTESTINAL ENDOSALPINGIOSIS - ABOUT 2 OBS ERVATIONS
Authors: LEBORGNE J NOMBALLAIS MF LEHUR PA GUIBERTEAUCANFRERE V MOUSSU P FUMOLEAU P
Citation: J. Leborgne et al., INTESTINAL ENDOSALPINGIOSIS - ABOUT 2 OBS ERVATIONS, Annales de Gastroenterologie et d'Hepatologie, 32(4), 1996, pp. 173-175
FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL
Authors: KHAYAT D BANZET P WEIL M FUMOLEAU P AVRIL MF NAMER M BONNETERRE J KERBRAT P BONERANDI JJ BUGAT R MONTCUQUET P CUPISSOL D LAUVIN R VILMER C BOAZIZ C COUR V BIZZARI JP
Citation: D. Khayat et al., FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL, Medicamentos de actualidad, 32, 1996, pp. 35-41
A MULTICENTER PHASE-II STUDY OF DOCETAXEL 75 MG M(-2) AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC
Authors: DIERAS V CHEVALLIER B KERBRAT P KRAKOWSKI I ROCHE H MISSET JL LENTZ MA AZLI N MURAWSKY M RIVA A POUILLART P FUMOLEAU P
Citation: V. Dieras et al., A MULTICENTER PHASE-II STUDY OF DOCETAXEL 75 MG M(-2) AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC, British Journal of Cancer, 74(4), 1996, pp. 650-656
A PHASE-II TRIAL OF DOCETAXEL IN PATIENTS (PTS) WITH ANTHRACYCLINE-RESISTANT (AR) METASTATIC BREAST-CANCER (MBC)
Authors: GUASTALLA JP BONNETERRE J FUMOLEAU P PICCART M TUBIANA M CHEVALLIER B NIEAMANN C ALAKL M NICHOL A RIVA A MARTY M
Citation: Jp. Guastalla et al., A PHASE-II TRIAL OF DOCETAXEL IN PATIENTS (PTS) WITH ANTHRACYCLINE-RESISTANT (AR) METASTATIC BREAST-CANCER (MBC), European journal of cancer, 31A, 1995, pp. 348-348
Risultati: 1-25 | 26-45